95656-88-5 (N-CBZ-3-羟基吡咯啉,Benzyl 3-hydroxypyrrolidine-1-carboxylate)

CAS号:
95656-88-5
中文名称:
N-CBZ-3-羟基吡咯啉
英文名称:
Benzyl 3-hydroxypyrrolidine-1-carboxylate
分子式:
C12H15NO3
分子量:
221.252403497696

N-CBZ-3-羟基吡咯啉(95656-88-5)名称与标识符

名称

中文别名:
N-CBZ-3-羟基吡咯啉;N-CBZ-3-羟基吡咯烷;(R)-1-Boc-3-羟基吡咯烷;2-(5-氨基-1H-吲唑-1-基)乙醇;N-苄氧羰基-3-羟基吡咯烷;N-CBZ-3-吡咯烷醇;
英文别名:
3-Hydroxy-1-N-Cbz-pyrrolidine;BENZYL 3-HYDROXYPYRROLIDINE-1-CARBOXYLATE;3-HYDROXY-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER;N-CBZ-3-HYDROXYPYRROLIDINE;1-Cbz-3-hydroxypyrrolidine;1-Pyrrolidinecarboxylic acid, 3-hydroxy-, phenylmethyl ester;3-Hydroxypyrrolidine-1-carboxylic acid benzyl ester;MBLJFGOKYTZKMH-UHFFFAOYSA-N;N-(benzyloxycarbonyl)-3-pyrrolidinol;N-CBZ-3-hydroxy pyrrolidine;Benzyl 3-hydroxy-1-pyrrolidinecarboxylate;N-CBZ-3-PYRROLIDINOL;1-Cbz-3-hydroxy-pyrrolidine;1-Pyrrolidinecarboxylicacid;Phenylmethyl 3-hydroxy-1-pyrrolidinecarboxylate (ACI);N-Benzyloxycarbonyl-3-hydroxypyrrolidine;N-Benzyloxycarbonyl-3-pyrrolidinol;PB17468;SY002311;CS-W003459;SY002310;(R)-Benzyl 3-hydroxypyrrolidine-1-carboxylate;FS-2447;benzyl3-hydroxypyrrolidine-1-carboxylate;AKOS012214203;Benzyl 3-hydroxy-1-pyrrolidinecarboxylate #;SCHEMBL492951;95656-88-5;DB-024709;3-Hydroxy-pyrrolidine-1-carboxylic acid, benzyl ester;AC-2599;(racemic)-N-carbobenzyloxy-3-pyrrolidinol;PB13059;MFCD08061949;EN300-202981;DTXSID30913871;PB23556;1-benzyloxycarbonyl-3-hydroxypyrrolidine;SY002312;J-524163;MFCD07368258;

标识符

MDL:
MFCD08061949
InChIKey:
MBLJFGOKYTZKMH-UHFFFAOYSA-N
Inchi:
1S/C12H15NO3/c14-11-6-7-13(8-11)12(15)16-9-10-4-2-1-3-5-10/h1-5,11,14H,6-9H2
SMILES:
O=C(N1CC(O)CC1)OCC1C=CC=CC=1

N-CBZ-3-羟基吡咯啉(95656-88-5)物化性质

实验特性

  • LogP : 1.32770
  • PSA : 49.77000
  • 折射率 : 1.589
  • 沸点 : 370.7°C at 760 mmHg
  • 熔点 : No data available
  • 蒸气压 : No data available
  • 闪点 : 178℃
  • 颜色与性状 : No data avaiable
  • 密度 : 1.1±0.1 g/cm3

计算特性

  • 精确分子量 : 221.10519334g/mol
  • 氢键供体数量 : 1
  • 氢键受体数量 : 3
  • 可旋转化学键数量 : 3
  • 同位素质量 : 221.10519334g/mol
  • 重原子数量 : 16
  • 复杂度 : 238
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 1
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 1.1
  • 拓扑分子极性表面积 : 49.8

N-CBZ-3-羟基吡咯啉(95656-88-5)安全信息

N-CBZ-3-羟基吡咯啉(95656-88-5)推荐厂家 更多厂家(33)

公司名称手机号/电话联系人QQ微信询单
苏州洪创医药科技有限公司 18151128828张经理 2506817824
询单
上海源叶生物科技有限公司 15026964105
15026964105
汤思磊 2881489226
询单
郑州阿尔法化工有限公司 15324716602
0371-55013243
刘经理 2853979810
询单
山东玖玥生物科技有限公司 15553333686张文杰 643971
询单
上海瀚思化工有限公司 18939883912
021-34536277
顾经理 3003949364
询单
铼博(上海)生化科技有限公司 13311756052
021-60536361 13311756052 13311756131
张经理 2851717387
询单
上海一基实业有限公司 13311756131
021-60548336 QQ:2355265332 QQ:2851717387
胡经理 2355265332
询单
上海一基实业有限公司 13311756052
021-60526763 13311756052 13311756131
胡经理 2355265332
询单
上海绩祥生物科技有限公司 13093077543陆经理 3985448220
询单
上海腾准生物科技有限公司 19821570922
021-34053661
张经理 3003871136
询单

N-CBZ-3-羟基吡咯啉(95656-88-5)合成路线

合成路线:1 步
反应条件:
参考文献:
Synthesis and biological studies of novel 2-aminoalkyl ethers as potential antiarrhythmic agents for the conversion of atrial fibrillation
Plouvier, Bertrand; Beatch, Gregory N.; Jung, Grace L.; Zolotoy, Alexander; Sheng, Tao; et al, Journal of Medicinal Chemistry, 2007, 50(12), 2818-2841
合成路线:1 步
反应条件:
参考文献:
Preparation of sulfonyl substituted (hetero)aromatic derivatives as RORγ inhibitors for treatment of autoimmune diseases
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Novel spiroheterocyclic compounds [morpholine-4-carboxylic acid amides of heterocyclic cyclohexylalanine and neopentylglycine derivatives and their analogs], useful as reversible inhibitors of cysteine proteases such as cathepsin S
, World Intellectual Property Organization, , ,
合成路线:1 步
参考文献:
Preparation and in vitro and in vivo evaluation of quinolones with selective activity against Gram-positive organisms
Cooper, Curt S.; Klock, Pamela L.; Chu, Daniel T. W.; Hardy, Dwight J.; Swanson, Robert N.; et al, Journal of Medicinal Chemistry, 1992, 35(8), 1392-8
合成路线:1 步
反应条件:
参考文献:
Preparation of azabicyclic derivatives of indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines for therapeutic use as α7-nACh receptor activators
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of phenyl amino pyrimidine bicyclic compounds useful as protein kinase inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Design of wogonin-inspired selective cyclin-dependent kinase 9 (CDK9) inhibitors with potent in vitro and in vivo antitumor activity
Wang, Jubo; Li, Tinghan; Zhao, Tengteng; Wu, Tizhi; Liu, Chuang; et al, European Journal of Medicinal Chemistry, 2019, 178, 782-801
合成路线:1 步
反应条件:
参考文献:
Pyrazolo[1,5-a]pyrimidine compounds as protein kinase inhibitors and their preparation, pharmaceutical compositions and their use in the treatment of protein kinase-mediated diseases
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Substituted pyridines as inhibitors of DNMT1 and their preparation
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of substituted heterocyclyl amides as Rho-associated protein kinase inhibitor and their use for treating or preventing diseases mediated by the Rho-associated protein kinase
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of Rho-associated protein kinase inhibitor
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Rho-associated protein kinase inhibitor, pharmaceutical composition containing rho-associated protein kinase inhibitor, preparation method and use of the pharmaceutical composition
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of 5-hydroxymethyloxazolidin-2-ones as antibacterials.
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of oxazolidinones linked to quinolones or naphthyridinones as antibacterials.
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of substituted azacycloalkanes β-secretase inhibitors for treating CNS condition
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of heterocyclic and aromatic ureas and amides as CEPT inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of aminocyclohexyl ethers as ion channel modulating compounds and therapeutic uses thereof
, United States, , ,